<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="08/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8600942" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8600942</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Organic_compound_other" id="A1">Surfactant</term> suppresses <term sem="Other" id="T1" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T2" lex="NF-kappa_B">NF-kappa B</term> activation</term> in human <term sem="Cell_natural" id="T3" lex="monocytic_cell">monocytic cells</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T2" />
<clue>Surfactant suppresses NF-kappa B <clueType>activation</clueType> in human monocytic cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E1" />
<cause idref="A1" />
<clue>Surfactant <clueType>suppresses</clueType> NF-kappa B activation <clueLoc>in human monocytic cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">In addition to biophysical properties, <term sem="Organic_compound_other" id="T4" lex="pulmonary_surfactant">pulmonary surfactant</term> has <term sem="Other" id="T5" lex="immunomodulatory_activity">immunomodulatory activity</term>.</sentence>
<sentence id="S3">We previously demonstrated that both synthetic (<term sem="Organic_compound_other" id="T6" lex="Exosurf">Exosurf</term>) and <term sem="Organic_compound_other" id="T7" lex="modified_natural_surfactant">modified natural surfactant</term> (<term sem="Organic_compound_other" id="T8" lex="Survanta">Survanta</term>) downregulated <term sem="Other" id="T9" lex="endotoxin-stimulated_inflammatory_c_ytokine_mRNA_level"><term sem="Lipid" id="A2">endotoxin</term>-stimulated <term sem="Protein_molecule" id="A3">inflammatory c ytokine</term> <term sem="RNA_molecule" id="A4">mRNA</term> levels</term> and <term sem="Protein_family_or_group" id="T11" lex="protein_product">protein products</term> (<term sem="Protein_molecule" id="T12" lex="tumor_necrosis_factor-alpha">tumor necrosis factor-alpha</term> [TNF], <term sem="Protein_molecule" id="T13" lex="interleukin-1-beta">interleukin-1-beta</term> [<term sem="Protein_molecule" id="T14" lex="IL-1">IL-1</term>], <term sem="Protein_molecule" id="T15" lex="interleukin-6">interleukin-6</term> [<term sem="Protein_molecule" id="T16" lex="IL-6">IL-6</term>]) in <term sem="Cell_natural" id="T17" lex="human_alveolar_macrophage">human alveolar <term sem="Cell_natural" id="T18" lex="macrophage">macrophages</term></term>.</sentence>
<event id="E3">
<type class="Positive_regulation" />
<theme idref1="A4" idref="A3" />
<cause idref="A2" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
<comment>NER T10 DEL</comment>
</event>
<event id="E4">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="T6" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E5">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="T8" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref1="T11" idref="A3" />
<cause idref="A2" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T12" />
<cause idref="A2" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T12">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T12">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event id="E8">
<type class="Positive_regulation" />
<theme idref="T14" />
<cause idref="A2" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T14">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T14">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event id="E9">
<type class="Positive_regulation" />
<theme idref="T16" />
<cause idref="A2" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) downregulated endotoxin-<clueType>stimulated</clueType> <corefTheme idref1="T16">inflammatory c ytokine</corefTheme> mRNA levels and <corefTheme idref1="T16">protein products</corefTheme> (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) in human alveolar macrophages.</clue>
</event>
<event id="E10">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="T6" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E11">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="T6" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E12">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T6" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E13">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="T6" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E14">
<type class="Negative_regulation" />
<theme idref="E6" />
<cause idref="T8" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E15">
<type class="Negative_regulation" />
<theme idref="E7" />
<cause idref="T8" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E16">
<type class="Negative_regulation" />
<theme idref="E8" />
<cause idref="T8" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<event id="E17">
<type class="Negative_regulation" />
<theme idref="E9" />
<cause idref="T8" />
<clue>We previously demonstrated that both synthetic (Exosurf) and modified natural surfactant (Survanta) <clueType>downregulated</clueType> endotoxin-stimulated inflammatory c ytokine mRNA levels and protein products (tumor necrosis factor-alpha [TNF], interleukin-1-beta [IL-1], interleukin-6 [IL-6]) <clueLoc>in human alveolar macrophages.</clueLoc></clue>
</event>
<sentence id="S4">In this study, we report that both <term sem="Organic_compound_other" id="T19" lex="Exosurf">Exosurf</term> and <term sem="Organic_compound_other" id="T20" lex="Survanta">Survanta</term> suppress <term sem="RNA_family_or_group" id="T21" lex="TNF_mRNA"><term sem="Protein_molecule" id="A5">TNF</term> mRNA</term> and secretion (85 +/- 4% mean percent inhibition +/- SEM by <term sem="Organic_compound_other" id="T22" lex="Exosurf">Exosurf</term>; 71 +/- 6% by <term sem="Organic_compound_other" id="T23" lex="Survanta">Survanta</term>) by <term sem="Cell_cultured" id="T24" lex="endotoxin-stimulated_THP-1"><term sem="Lipid" id="A6">endotoxin</term>-stimulated <term sem="Cell_cultured" id="A7">THP-1</term></term>, a <term sem="Cell_cultured" id="T25" lex="human_monocytic_cell_line">human monocytic cell line</term>.</sentence>
<event id="E18">
<type class="Negative_regulation" />
<theme idref="T21" />
<cause idref="T19" />
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line</clueLoc>.</clue>
</event>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="T21" />
<cause idref="T20" />
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line</clueLoc>.</clue>
</event>
<event id="E20">
<type class="Localization" />
<theme idref="A5" />
<clue>In this study, we report that both Exosurf and Survanta suppress TNF mRNA and <clueType>secretion</clueType> (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) <clueLoc>by endotoxin-stimulated THP-1, a human monocytic cell line.</clueLoc></clue>
</event>
<event id="E21">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="T19" />
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-stimulated THP-1, a human monocytic cell line.</clue>
</event>
<event id="E22">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="T20" />
<clue>In this study, we report that both Exosurf and Survanta <clueType>suppress</clueType> TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-stimulated THP-1, a human monocytic cell line.</clue>
</event>
<event id="E51">
<type class="Physiological_process" />
<theme idref="A7" />
<cause idref="A6" />
<clue>In this study, we report that both Exosurf and Survanta suppress TNF mRNA and secretion (85 +/- 4% mean percent inhibition +/- SEM by Exosurf; 71 +/- 6% by Survanta) by endotoxin-<clueType>stimulated</clueType> THP-1, a human monocytic cell line.</clue>
</event>
<sentence id="S5">Because <term sem="Lipid" id="A8">surfactant</term> downregulated <term sem="Other" id="T26" lex="inflammatory_cytokine_production"><term sem="Protein_family_or_group" id="T27" lex="inflammatory_cytokine">inflammatory cytokine</term> production</term> similarly in both <term sem="Cell_natural" id="T28" lex="normal_human_alveolar_macrophage">normal human alveolar <term sem="Cell_natural" id="T29" lex="macrophage">macrophages</term></term> and the <term sem="Cell_cultured" id="T30" lex="THP-1_cell_line">THP-1 cell line</term>, we used this <term sem="Cell_cultured" id="T31" lex="cell_line">cell line</term> to investigate whether <term sem="Lipid" id="A9">surfactant</term> affected <term sem="Other" id="T32" lex="transcriptional_mechanism">transcriptional mechanisms</term>.</sentence>
<event id="E23">
<type class="Gene_expression" />
<theme idref="T27" />
<clue>Because surfactant downregulated inflammatory cytokine <clueType>production</clueType> similarly in both normal human alveolar macrophages and the THP-1 cell line, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event id="E300">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="A8" />
<clue>Because surfactant <clueType>downregulated</clueType> inflammatory cytokine production similarly <clueLoc>in</clueLoc> both <clueLoc>normal human alveolar macrophages</clueLoc> and the THP-1 cell line, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event id="E301">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="A8" />
<clue>Because surfactant <clueType>downregulated</clueType> inflammatory cytokine production similarly <clueLoc>in</clueLoc> both normal human alveolar macrophages and <clueLoc>the THP-1 cell line</clueLoc>, we used this cell line to investigate whether surfactant affected transcriptional mechanisms.</clue>
</event>
<event uncertainty="doubtful" id="E25">
<type class="Regulation" />
<theme idref="T32" />
<cause idref="A9" />
<clue>Because surfactant downregulated inflammatory cytokine production similarly in both normal human alveolar macrophages and the THP-1 cell line, we used this cell line to investigate whether surfactant <clueType>affected</clueType> transcriptional mechanisms.</clue>
</event>
<sentence id="S6">Specifically, we examined <term sem="Other" id="T33" lex="nuclear_factor-kappa_B_(NF-kappa_B)_activation"><term sem="Protein_complex" id="T34" lex="nuclear_factor-kappa_B">nuclear factor-kappa B</term> (<term sem="Protein_complex" id="T35" lex="NF-kappa_B">NF-kappa B</term>) activation</term> because it is crucial in <term sem="Other" id="T36" lex="transcriptional_regulation">transcriptional regulation</term> of many <term sem="DNA_family_or_group" id="T37" lex="inflammatory_cytokine_gene"><term sem="Protein_family_or_group" id="T38" lex="inflammatory_cytokine">inflammatory cytokine</term> genes</term> including <term sem="DNA_domain_or_region" id="T39" lex="TNF">TNF</term>, <term sem="DNA_domain_or_region" id="T40" lex="IL-1">IL-1</term>, and <term sem="DNA_domain_or_region" id="T41" lex="IL-6">IL-6</term>.</sentence>
<event uncertainty="doubtful" id="E26">
<type class="Positive_regulation" />
<theme idref="T35" />
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) <clueType>activation</clueType> because it is crucial in transcriptional regulation of many inflammatory cytokine genes including TNF, IL-1, and IL-6.</clue>
</event>
<event id="E27">
<type class="Regulation" />
<theme idref="T37" />
<cause idref="T35" />
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> many inflammatory cytokine genes including TNF, IL-1, and IL-6.</clue>
</event>
<event id="E28">
<type class="Regulation" />
<theme idref="T39" />
<cause idref="T35" />
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<event id="E29">
<type class="Regulation" />
<theme idref="T40" />
<cause idref="T35" />
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<event id="E30">
<type class="Regulation" />
<theme idref="T41" />
<cause idref="T35" />
<clue>Specifically, we examined nuclear factor-kappa B (NF-kappa B) activation because it is crucial in <clueType>transcriptional regulation</clueType> <linkTheme>of</linkTheme> <corefTheme>many inflammatory cytokine genes</corefTheme> including TNF, IL-1, and IL-6.</clue>
</event>
<sentence id="S7"><term sem="Other" id="T42" lex="electrophoretic_mobility_shift_assays">Electrophoretic mobility shift assays</term> showed that both <term sem="Organic_compound_other" id="T43" lex="surfactant">surfactants</term> decreased activation of <term sem="Protein_complex" id="T44" lex="NF-kappa_B">NF-kappa B</term>.</sentence>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="T44" />
<clue>Electrophoretic mobility shift assays showed that both surfactants decreased <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B.</clue>
</event>
<event id="E32">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T19" />
<clue>Electrophoretic mobility shift assays showed that <corefCause>both surfactants</corefCause> <clueType>decreased</clueType> activation of NF-kappa B.</clue>
</event>
<event id="E33">
<type class="Negative_regulation" />
<theme idref="E31" />
<cause idref="T20" />
<clue>Electrophoretic mobility shift assays showed that <corefCause>both surfactants</corefCause> <clueType>decreased</clueType> activation of NF-kappa B.</clue>
</event>
<sentence id="S8">The presence of both <term sem="Protein_molecule" id="T45" lex="p65">p65</term> and <term sem="Protein_molecule" id="T46" lex="p50">p50</term> <term sem="Protein_molecule" id="T47" lex="NF-kappa_B_component"><term sem="Protein_complex" id="T48" lex="NF-kappa_B">NF-kappa B</term> components</term> in <term sem="Lipid" id="T49" lex="LPS">LPS</term>-activated <term sem="Cell_cultured" id="T50" lex="THP-1_cell">THP-1 cells</term> was confirmed by specific <term sem="Other" id="T51" lex="antibody_induction">antibody induction</term> of supershifts in <term sem="Other" id="T52" lex="mobility_assay">mobility assays</term>.</sentence>
<event id="E34">
<type class="Physiological_process" />
<theme idref="T50" />
<cause idref="T49" />
<clue>The presence of both p65 and p50 NF-kappa B components in LPS-<clueType>activated</clueType> THP-1 cells was confirmed by specific antibody induction of supershifts in mobility assays.</clue>
</event>
<event id="E35">
<type class="Gene_expression" />
<theme idref="T45" />
<clue>The <clueType>presence</clueType> <linkTheme>of</linkTheme> both p65 and p50 NF-kappa B components <clueLoc>in LPS-activated THP-1 cells</clueLoc> was confirmed <clueExperiment>by specific antibody induction of supershifts in mobility assays.</clueExperiment></clue>
</event>
<event id="E50">
<type class="Gene_expression" />
<theme idref="T46" />
<clue>The <clueType>presence</clueType> <linkTheme>of</linkTheme> both p65 and p50 NF-kappa B components <clueLoc>in LPS-activated THP-1 cells</clueLoc> was confirmed <clueExperiment>by specific antibody induction of supershifts in mobility assays.</clueExperiment></clue>
</event>
<sentence id="S9">These results are the first to suggest that surfactant&apos;s suppressive effects on <term sem="Other" id="T53" lex="inflammatory_cytokine_production"><term sem="Protein_family_or_group" id="T54" lex="inflammatory_cytokine">inflammatory cytokine</term> production</term> may involve <term sem="Other" id="T55" lex="transcriptional_regulation">transcriptional regulation</term> through inhibition of <term sem="Other" id="T56" lex="NF-kappa_B_activation"><term sem="Protein_complex" id="T57" lex="NF-kappa_B">NF-kappa B</term> activation</term>.</sentence>
<event id="E36">
<type class="Gene_expression" />
<theme idref="T54" />
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine <clueType>production</clueType> may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event id="E37">
<type class="Negative_regulation" />
<theme idref="E36" />
<cause idref="T19" />
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> <clueType>suppressive</clueType> effects <linkTheme>on</linkTheme> inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event id="E38">
<type class="Negative_regulation" />
<theme idref="E36" />
<cause idref="T20" />
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> <clueType>suppressive</clueType> effects <linkTheme>on</linkTheme> inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B activation.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="T57" />
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine production may involve transcriptional regulation through inhibition of NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event id="E40">
<type class="Negative_regulation" />
<theme idref="E39" />
<cause idref="T19" />
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> suppressive effects on inflammatory cytokine production may involve transcriptional regulation through <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation.</clue>
</event>
<event id="E41">
<type class="Negative_regulation" />
<theme idref="E39" />
<cause idref="T20" />
<clue>These results are the first to suggest that <corefCause>surfactant&apos;s</corefCause> suppressive effects on inflammatory cytokine production may involve transcriptional regulation through <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappa B activation.</clue>
</event>
<event uncertainty="probable" id="E42">
<type class="Regulation" />
<theme idref="E37" />
<cause idref="E40" />
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine production may involve <clueType>transcriptional regulation</clueType> <linkCause>through</linkCause> inhibition of NF-kappa B activation.</clue>
</event>
<event uncertainty="probable" id="E43">
<type class="Regulation" />
<theme idref="E38" />
<cause idref="E41" />
<clue>These results are the first to suggest that surfactant&apos;s suppressive effects on inflammatory cytokine production may involve <clueType>transcriptional regulation</clueType> <linkCause>through</linkCause> inhibition of NF-kappa B activation.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
